Dr Paul E Mayes, MD | |
2129 W Davis St, D, Conroe, TX 77304-1942 | |
(936) 788-1600 | |
(936) 788-1601 |
Full Name | Dr Paul E Mayes |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 2129 W Davis St, Conroe, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912995622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 12292R (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Paul E Mayes, MD 2129 W Davis St, D, Conroe, TX 77304-1942 Ph: (936) 788-1600 | Dr Paul E Mayes, MD 2129 W Davis St, D, Conroe, TX 77304-1942 Ph: (936) 788-1600 |
News Archive
Looking at pictures of natural vulvas in a range of shapes and sizes could help improve women's satisfaction with their own genitalia, even those with a relatively positive genital self-image, according to new research published in the Journal of Psychosomatic Obstetrics & Gynecology.
Kent medical device manufacturer, Bedfont Scientific Ltd., signs a multiyear ODM deal to supply MGC Diagnostics Corporation with its new NObreath®.
Pacira Pharmaceuticals, Inc. today announced the commercial launch of EXPAREL (bupivacaine liposome injectable suspension) in the United States. Starting today, EXPAREL will begin shipping to hospital and ambulatory care customers through their normal wholesaler and distributor channels.
Implants are usually the first choice for breast reconstruction after mastectomy. But when implant-based reconstruction fails, autologous reconstruction - using the patient's own tissues - is a safe procedure that improves patient outcomes, reports a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 5 days ago
Kayla Panos, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 17600 Interstate 45 S, Conroe, TX 77384 Phone: 936-267-7391 | |
Samuel J Alianell, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3275 College Park Dr, Conroe, TX 77384 Phone: 936-321-0214 Fax: 936-271-0219 | |
Mrs. Julie M Quinn, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 504 Medical Center Blvd, Conroe, TX 77304 Phone: 936-539-7086 | |
Shawn Pratt, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1150 N Loop 336 W, Conroe, TX 77301 Phone: 814-494-3777 | |
Kendall Nicole Delue, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 15210 Interstate 45 S Ste 108, Conroe, TX 77384 Phone: 832-702-7272 | |
Briana Davis, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3400 N Loop 336 W Apt 715, Conroe, TX 77304 Phone: 936-446-0825 |